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Commun i c a t i o n
I N T RODUC T I ON
The cardiac ryanodine receptor (RyR2), an intracellu-
lar Ca2+ release channel, plays a key role in excitation-
contraction coupling in the heart. Depolarization of the 
sarcolemma opens voltage-dependent L-type Ca2+ chan-
nels (dihydropyridine receptors), which allows Ca2+ to 
enter the cell. The subsequent increase in cytoplasmic 
Ca2+ activates RyR2, which releases Ca2+ from the SR. 
Intracellular Ca2+, Mg2+, and ATP are allosteric regula-
tors of RyR2 (Meissner and Henderson, 1987; Meissner, 
1994; Laver and Honen, 2008) that play an important 
role in determining normal cardiac contraction and 
rhythmicity (Meissner, 1994; Bers, 2002), and their dis-
ruption can lead to sudden cardiac death (Blayney and 
Lai, 2009; Katz et al., 2009). Ca2+ in the SR lumen and 
cytoplasm activates RyR2, whereas Mg2+ (free concen-
tration of 1 mM in cytoplasm and lumen [Meissner, 
1994]) is a channel inhibitor. During diastole, cytoplas-
mic and SR luminal Ca2+ concentrations are 100 nM 
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and 1 mM, respectively (Ginsburg et al., 1998). During 
systole, clusters of RyR2s release Ca2+ into the confined 
region between the SR and sarcolemma/T-tubule mem-
brane. Computer simulations of Ca2+ release estimate that 
cytoplasmic Ca2+ concentration near the RyR2 peaks at 
200 µM and that luminal Ca2+ declines to 200 µM 
(Laver et al., 2013).
Single channel studies of RyR2 isolated from animal 
hearts (e.g. sheep, rat and dog) have provided valuable 
insights into the regulation of RyR2 by intracellular Ca2+, 
Mg2+, and ATP (Sitsapesan and Williams, 1997; Györke 
et al., 2002; Laver, 2005, 2007; Györke and Terentyev, 
2008). These studies provide evidence for four different 
Ca2+-dependent mechanisms, controlled by four Ca2+/
Mg2+ sites on each RyR2 subunit (Laver, 2010). RyR2 can 
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Regulation of the cardiac ryanodine receptor (RyR2) by intracellular Ca2+ and Mg2+ plays a key role in determining 
cardiac contraction and rhythmicity, but their role in regulating the human RyR2 remains poorly defined. The Ca2+- 
and Mg2+-dependent regulation of human RyR2 was recorded in artificial lipid bilayers in the presence of 2 mM ATP 
and compared with that in two commonly used animal models for RyR2 function (rat and sheep). Human RyR2 dis-
played cytoplasmic Ca2+ activation (Ka = 4 µM) and inhibition by cytoplasmic Mg2+ (Ki = 10 µM at 100 nM Ca2+) that 
was similar to RyR2 from rat and sheep obtained under the same experimental conditions. However, in the presence 
of 0.1 mM Ca2+, RyR2s from human were 3.5-fold less sensitive to cytoplasmic Mg2+ inhibition than those from sheep 
and rat. The Ka values for luminal Ca2+ activation were similar in the three species (35 µM for human, 12 µM for 
sheep, and 10 µM for rat). From the relationship between open probability and luminal [Ca2+], the peak open prob-
ability for the human RyR2 was approximately the same as that for sheep, and both were 10-fold greater than that 
for rat RyR2. Human RyR2 also showed the same sensitivity to luminal Mg2+ as that from sheep, whereas rat RyR2 was 
10-fold more sensitive. In all species, modulation of RyR2 gating by luminal Ca2+ and Mg2+ only occurred when cyto-
plasmic [Ca2+] was <3 µM. The activation response of RyR2 to luminal and cytoplasmic Ca2+ was strongly dependent 
on the Mg2+ concentration. Addition of physiological levels (1 mM) of Mg2+ raised the Ka for cytoplasmic Ca2+ to 30 µM 
(human and sheep) or 90 µM (rat) and raised the Ka for luminal Ca2+ to 1 mM in all species. This is the first report 
of the regulation by Ca2+ and Mg2+ of native RyR2 receptor activity from healthy human hearts.
© 2014 Walweel et al. This article is distributed under the terms of an Attribution–Non-
commercial–Share Alike–No Mirror Sites license for the first six months after the publication 
date (see http://www.rupress.org/terms). After six months it is available under a Creative 
Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de-
scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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264 Regulation of human RyR2
hearts were snap frozen in liquid nitrogen (196°C) in not more 
than 4 h, and usually within 3 h, of death. Human tissues were 
obtained with approval from the Human Research Ethics Com-
mittees of both the University of Newcastle (approval number 
H-2009-0369) and the University of Sydney (approval numbers 
#09-2009-12146 and #2012/2814).
Animal tissues were obtained with approval from the Animal 
Care and Ethics Committee of the University of Newcastle (ap-
proval number #A-2009-153). Sheep hearts were obtained from 
ewes anesthetized with 5% pentobarbitone (intravenously) fol-
lowed by oxygen/halothane and killed by barbiturate overdose 
(pentobarbitone, 150 mg/kg intravenously) before the heart was 
removed. Rat heart tissue was obtained from male rats (Sprague-
Dawley, 6–9 wk). Rats were anesthetized with isoflurane and then 
decapitated. Hearts were rapidly removed and perfused in a Lan-
gendorff apparatus. The blood was removed by flushing the 
hearts with ice-cold Krebs-Henseleit buffer (mM: 120 NaCl, 25 
NaHCO3, 10 glucose, 5 KCl, 2 MgCl2, 1 NaH2PO4, and 2.5 CaCl2) 
for 2 min. Hearts were then perfused with warmed (37°C) and 
oxygenated (95% O2–5% CO2) Krebs-Henseleit buffer for 5 min. 
After perfusion, the whole hearts were snap frozen in liquid N2. 
All tissue samples were stored at 80°C.
Preparation of SR vesicles
Heart muscle was minced and homogenized in a Waring blender 
(four 15-s bursts at high speed) in homogenizing buffer containing 
0.3 M sucrose, 10 mM imidazole, 0.5 mM PMSF, 1 µg/ml leupeptin, 
1 µg/ml pepstatin A, 1 mM benzamidine, 0.5 mM dithiothreitol, 
3 mM NaN3, and 20 mM NaF, pH 6.9, followed by 10 manual 
strokes of a loose glass/glass Dounce homogenizer. The homog-
enate was centrifuged at 8,000 g for 20 min using an Optima 
L-100XP ultracentrifuge (Beckman Coulter). The supernatant 
was then centrifuged at 170,000 g for 30 min. The resultant pellet 
was resuspended with homogenizing buffer containing 0.65 M 
KCl using a glass/glass Dounce homogenizer, incubated for 30 min 
on ice, and then centrifuged at 8,000 g for 15 min. The supernatant 
was centrifuged at 170,000 g for 1 h, and the resulting microsomes 
from the pellet were resuspended in storage buffer (homogeniz-
ing buffer + 0.65 M KCl), snap-frozen in liquid nitrogen, and 
stored at 80°C.
Single channel measurements
RyRs from human, rat, and sheep heart were incorporated into 
artificial lipid bilayers that were formed from phosphatidyletha-
nolamine and phosphatidylcholine (8:2 wt/wt) in 50 mg/ml 
n-decane. For single channel recording, the cis (cytoplasmic) and 
trans (luminal) solutions contained 250 mM Cs+ (230 mM cesium 
methanesulfonate and 20 mM cesium chloride). During record-
ings, the composition of trans solution was altered by means of ali-
quot additions of stock solutions, and the cis solution was 
exchanged for solutions with specified free Ca2+ and Mg2+. Solu-
tion exchange was performed using continuous local perfusion 
via a tube placed in close proximity to the bilayer, which could 
produce solution change within 1 s.
be activated by Ca2+ binding to either the cytoplasmic 
side of the channel with 2 µM affinity (A site [Smith 
et al., 1986; Hymel et al., 1988; Sitsapesan and Williams, 
1994a]) or to the luminal side of the channel with 0.1 mM 
affinity (L site [Sitsapesan and Williams, 1994b; Laver, 
2007]). In addition, two mechanisms for cytoplasmic 
Ca2+ inhibition of RyR2 have been identified, with chan-
nels inhibited by millimolar concentrations of cytoplas-
mic Ca2+ at the I1 site (Meissner, 1986; Laver et al., 1995) 
and partially inhibited by micromolar concentrations at 
the I2 site (Laver, 2007). Mg2+ inhibits RyR2 by compet-
ing with Ca2+ at the A site (Smith et al., 1986) and the L 
site (Laver and Honen, 2008) where, unlike Ca2+, Mg2+ 
binding does not cause channel opening. Mg2+ also in-
hibits RyR2 because it acts as a surrogate for Ca2+ at the 
I1 site (Laver et al., 1997a).
Interest in the function of human RyR2 has been 
spurred by the recent understanding that heart dys-
function associated with heart failure is generally associ-
ated with aberrant Ca2+ fluxes across the sarcolemma 
and SR of cardiac cells (Bers et al., 2003). Although the 
regulation of human RyR2 by intracellular Ca2+ and 
Mg2+ is central to our understanding of SR Ca2+ fluxes, 
its regulation characteristics are still sparsely defined 
(Marx et al., 2000; Jiang et al., 2002). One study has ex-
amined cytoplasmic Ca2+ activation, and this was done 
using recombinant human RyR2 (Wehrens et al., 2004). 
Here we present the first analysis of RyR2 isolated from 
human heart and its regulation by intracellular Ca2+ 
and Mg2+. We also compare these gating properties of 
human RyR2 with RyR2 from sheep and rat heart (two 
commonly used animal models for RyR2 function).
MAT E R I A L S  AND  M E THOD S
Heart tissue
Human left ventricle tissue (n = 4) was obtained from healthy 
donor hearts (Table 1 summarizes the donor heart details). These 
hearts were collected at the site of organ donation by the St. Vin-
cent’s Hospital (Darlinghurst) surgical team. The hearts were 
flushed with ice-cold cardioplegia, packaged under sterile condi-
tions, transported by the Australian Red Cross Blood Service and 
delivered to the Bosch Institute. Although these hearts showed no 
sign of disease, they were not required for orthotopic heart trans-
plantation for a range of reasons, including tissue incompatibility. 
Trans-mural sections of left ventricle free wall (1 g) from these 
TA B L E  1
Characteristics of hearts (Human Heart Tissue Repository, University of Sydney)
Sample Section Sex Age Cause of death Po (n)
6.008 LV M 40 Stroke 0.06 ± 0.02 (20)
6.028 LV F 62 Hypoxic brain injury 0.10 ± 0.05 (18)
7.012 LV M 19 Motor cycle accident 0.05 ± 0.03 (2)
6.048 LV F 54 Subarachnoid hemorrhage 0.12 ± 0.06 (16)
Hearts were not required for organ transplantation. The open probability (mean ± SEM) was measured in the presence of 100 nM cytoplasmic Ca2+ and 
0.1 mM luminal Ca2+ from n experiments. LV, left ventricle.
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Acquisition and analysis of ion channel recordings
An Axopatch 200B amplifier (Molecular Devices) was used to con-
trol the bilayer potential and record unitary currents. Electrical 
potential differences were expressed as cytoplasmic potential rel-
ative to the luminal potential (at virtual ground). The channel 
currents were recorded during the experiments using a 50-kHz 
sampling rate and 5-kHz low pass filtering. Before analysis, the 
current signal was redigitized at 5 kHz and low pass filtered at 
1 kHz with a Gaussian digital filter. Single channel open probabil-
ity (Po) was measured using a threshold discriminator at 50% of 
channel amplitude. These parameters were measured from single 
channel records using Channel3 software (Nicholas W. Laver). 
Unless otherwise stated, measurements were performed with the 
cis solution voltage clamped at 40 mV.
Statistics
Unless otherwise stated, data are presented as means ± SEM. Indi-
vidual readings of open probability were derived from 30–200 s 
of RyR2 recording depending on experimental conditions. At 
All solutions were buffered using 10 mM TES (N-Tris[hydroxy-
methyl] methyl-2-aminoethanesulfonic acid; ICN Biomedicals) 
and titrated to pH 7.4 using CsOH (ICN Biomedicals). A Ca2+ 
electrode (Radiometer) was used in our experiments to deter-
mine the purity of Ca2+ buffers and Ca2+ stock solutions as well as 
free [Ca2+] when [Ca2+] was >100 nM. Free Ca2+ was adjusted with 
CaCl2 and buffered using either (a) 4.5 mM BAPTA (1,2-bis(o-
aminophenoxy)ethane- N,N,N,N-tetraacetic acid; Invitrogen) for 
free [Ca2+] < 1 µM, (b) dibromo BAPTA (up to 2 mM) for free 
[Ca2+] between 1 and 10 µM, or (c) sodium citrate (up to 6 mM) 
for free [Ca2+] between 10 and 50 µM (sodium citrate was only 
used as a buffer in the absence of Mg2+). Because all solutions ap-
plied in the cis bath contained ATP (ATP chelates Ca2+ and Mg2+), 
free levels of Mg2+ (added as MgCl2) were calculated using esti-
mates of ATP purity and effective Mg2+ binding constants that 
were determined previously under our experimental conditions 
(Laver et al., 2004). The cesium salts were obtained from Sigma-
Aldrich; CaCl2 and MgCl2 were obtained from BDH Chemicals.
Figure 1. RyR2 regulation by cytoplasmic Ca2+ and Mg2+. (A) Single channel recordings of RyR2 from healthy human heart with cytoplasmic 
[Ca2+] indicated to the left of each trace. Channel recordings were taken in the virtual absence of luminal Ca2+ (1 nM) and in the presence of 
2 mM ATP in the cytoplasm. Membrane potential is at 40 mV, and channel openings are downward current jumps from the baseline (arrows). 
(B) Cytoplasmic Ca2+ dependence of RyR2 Po from human, sheep, and rat (as indicated in the legend, which also applies to D) under the same 
experimental conditions. (C) Single channel recordings of human RyR2 with cytoplasmic [Mg2+] indicated to the left of each trace. Channel 
recordings were taken in the presence of cytoplasmic pCa 7 and 2 mM ATP (luminal pCa 4). (D) Inhibition of RyR2 by cytoplasmic [Mg2+] 
in the presence of both cytoplasmic pCa 7 and pCa 4 and luminal pCa 4. The number of experiments and the Hill parameters are listed in 
Table 2. Data for rat at pCa 7 and sheep RyR2 in D were obtained from Li et al. (2013) and Laver and Honen (2008). Error bars indicate SEM.
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525 ± 10 pS (n = 6) for sheep RyRs and 460 ± 10 pS (n = 6) 
for rat RyR2s obtained under the same conditions. We 
compared the gating kinetics of cardiac RyR2s from four 
healthy human hearts (see Table 1 for source informa-
tion). Myocytes from these four hearts were previously 
found to have contractility and Ca2+ handling properties 
that are consistent with healthy donor hearts (Wijnker 
et al., 2011; van Dijk et al., 2012; Hamdani et al., 2013; 
Mollova et al., 2013; Sequeira et al., 2013). We found no 
significant difference in open probability, Po, among RyRs 
from these four hearts (Table 1). Therefore, in our analy-
sis of the concentration dependencies of cytoplasmic 
and luminal Ca2+ and Mg2+ regulation of RyR2, the data 
were pooled from all heart samples. Regulation by in-
tracellular Ca2+ and Mg2+ of human RyR2 was compared 
moderate to high levels of RyR2 activation, 103 to 104 opening 
events were recorded for each condition. At low levels of RyR ac-
tivity, care was taken to ensure that the duration of recordings was 
sufficient to capture at least 30 channel openings. Hill equations 
were fitted to the dose–response data by the method of least 
squares, and errors on the Hill equation parameters were derived 
using the simplex method. The significance of the parameter dif-
ferences between species was tested using Student’s t test with a 
p-value <0.05 defining statistical significance.
R E S U L T S
Ionic conductance
Human RyR2 incorporated into lipid bilayers had a ce-
sium ion conductance of 575 ± 5 pS (n = 6) in symmetric 
250 mM CsCl ([Ca2+] < 1 µM), which is close to values of 
Figure 2. RyR2 regulation by luminal Ca2+ and Mg2+. (A) Single channel recordings of RyR2 from healthy human heart with luminal 
[Ca2+] indicated to the left of each trace. Channel recordings were taken in the presence of 100 nM cytoplasmic Ca2+ (pCa 7) and 2 mM 
ATP in the cytoplasm at 40 mV. Channel openings are downward current jumps from the baseline (arrows). (B) Effect of luminal Ca2+ 
on RyR2 Po from human, sheep, and rat as indicated in the legend (legend also applies to D). The luminal [Ca2+] activation response 
of RyR2 was obtained using cytoplasmic pCa 7 and 2 mM ATP. (C) Po of RyR2 from human, sheep, and rat in the presence of various 
combinations of cytoplasmic and luminal [Ca2+]. Asterisks indicate significant difference to luminal pCa 9 (*, P < 0.05). (D) Luminal 
[Mg2+] inhibition response of RyR2 with cytoplasmic pCa 7 (2 mM ATP) and luminal pCa 4. The solid and dashed curves show Hill fits 
to the data. The number of experiments and the Hill parameters for rat and sheep RyR2 are listed in Table 3. Data points show the mean 
± SEM. Data for rat RyR2 in B and D were obtained from Li et al. (2013).
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fixed levels of [Ca2+] (Fig. 1, C and D; and Fig. 2 D). Fig. 3 
then shows cytoplasmic and luminal regulation by Ca2+ 
at a physiological level of Mg2+.
RyR2 from human, sheep, and rat were strongly acti-
vated by cytoplasmic Ca2+ alone (i.e., in the virtual ab-
sence of luminal Ca2+, 1 nM; Fig. 1 A). The Po of RyR2 
from the three species was 104 at submicromolar 
Ca2+ (i.e., pCa 9 to 7) and increased to near unity at 
with RyR2 from rat and sheep, two commonly used animal 
models for RyR2 function. The rationale for the experi-
mental conditions in the three figures in this study is as 
follows: The cytoplasmic and luminal regulatory sites on 
the RyR2 (Figs. 1 and 2, respectively) involve regulation 
by both Mg2+ and Ca2+. Hence, we initially show regula-
tion by Ca2+ in the absence of Mg2+ (Fig. 1, A and B; and 
Fig. 2, A–C) and then regulation by Mg2+ with certain 
TA B L E  2
The Hill fit parameters for cytoplasmic regulation data shown in Fig. 1
Species [Ca2+]L pCa [Ca2+]C pCa Pmax Pmin (×103) Ka/Ki Ha/Hi n
µM
Activation by cytoplasmic Ca2+
Human 9 - 0.9 ± 0.3 0.14 ± 0.02 4.0 ± 1.0 2.5 ± 0.4 4–6
Sheep 9 - 0.90 ± 0.03 0.15 ± 0.08 2.0 ± 0.3 2.6 ± 1.3 4–5
Rat 9 - 0.60 ± 0.10 0.20 ± 0.05 3.2 ± 0.5 2.8 ± 0.5 4
Inhibition by cytoplasmic Mg2+
Human 4 7 0.03 ± 0.02 0a 15 ± 4 1.2 ± 0.5 4
Sheep 4 7 0.19 ± 0.06 0a 18 ± 3 1.4 ± 0.3 3–26
Rat 4 7 0.019 ± 0.015 0a 13 ± 6 1.3 ± 0.7 10
Human 4 4 0.90 ± 0.06 0a 5,400 ± 800 0.8 ± 0.2 4–10
Sheep 4 4 0.98 ± 0.10 0a 1,600 ± 300b 0.7 ± 0.3 4–7
Rat 4 4 0.95 ± 0.03 0a 5,500 ± 600 1.6 ± 0.7 5
n indicates the number of experiments. The Hill equation for Ca2+ activation is
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Figure 3. Ca2+ regulation of RyR2 in the presence of 1 mM Mg2+. (A) Cytoplasmic [Ca2+] activation response of RyR2 in the presence of 
1 mM free Mg2+ and 2 mM ATP in the cytoplasm (luminal pCa 4). RyR2 from human, sheep, and rat are indicated in the legend (legend 
applies to A and B). (B) Luminal [Ca2+] activation response of RyR2 in the presence of 1 mM luminal Mg2+ (cytoplasmic pCa 7 and 
2 mM ATP). Data points show the mean ± SEM. The solid and dashed curves show Hill fits to the data. The numbers of experiments and 
the Hill parameters are listed in Table 4. Data for rat RyR2 in A were obtained from Cannell et al. (2013). Numbers of experiments in B 
were three to six for human, two to four for rat, and four for sheep.
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sheep, and rat, but the effect of luminal Ca2+ on RyR2 ac-
tivity was negligible once RyRs were appreciably acti-
vated by cytoplasmic Ca2+ at pCa 5.5 (3 µM).
Millimolar concentrations of Mg2+ added to the lumi-
nal bath inhibited RyRs from human, sheep, and rat at 
cytoplasmic pCa 7, and the luminal [Mg2+] dependen-
cies of Po are shown in Fig. 2 D and Table 3. RyR2s from 
human and sheep heart showed a similar dependence 
on luminal Mg2+, whereas rat RyR2 showed a markedly 
different dependence. Hill fits to the data show Ki values 
for luminal Mg2+ inhibition of 550 µM, 650 µM, and 78 µM 
for human, sheep, and rat RyR2s, respectively. Interest-
ingly, the higher Hill coefficient for the luminal [Mg2+] 
response of human and sheep RyRs compensated for 
the differences in Ki, leaving no significant difference in 
the levels of inhibition at physiological (1 mM) luminal 
Mg2+ for all species.
Ca2+ activation in the presence of [Mg2+]
To assess the gating properties of RyR2 at physiological 
(systolic) concentrations of Ca2+ and Mg2+, we measured 
the activation of RyR2 by luminal and cytoplasmic Ca2+ in 
the presence of 1 mM Mg2+ (Fig. 3). Fig. 3 A and Table 4 
show the cytoplasmic [Ca2+] dependence of Po in the 
presence of cytoplasmic 1 mM free Mg2+ and 2 mM ATP. 
The lower limit to the experimental cytoplasmic [Ca2+] 
range was set by the minimum Po that we could reliably 
measure (Po  104). Under these conditions, human 
RyR2 had a Ka for Ca2+ activation of 25 ± 8 µM and a 
maximum Po of 0.55 ± 0.1. In the presence of 1 mM cyto-
plasmic Mg2+, RyR2 from human and sheep have similar 
Ca2+ activation properties, whereas RyR2 from rat is 
threefold less sensitive to cytoplasmic Ca2+ (P < 0.01).
The luminal Ca2+ activation properties of RyR2 chan-
nels from human, sheep, and rat in the presence of 1 mM 
luminal Mg2+ (without cytoplasmic Mg2+) are shown in 
Fig. 3 B. The near linear luminal Ca2+ dependencies of 
RyR Po seen here are substantially different to the strongly 
micromolar concentrations (pCa 5 and 4). Activation of 
RyR2 showed no significant differences between species 
in their sensitivity to cytoplasmic Ca2+ with Ka values of 
4 µM, 3.2 µM, and 2.0 µM for human, rat, and sheep, 
respectively (Fig. 1 B and Table 2).
The inhibitory effects of cytoplasmic Mg2+ at cytoplas-
mic [Ca2+] of 100 nM (pCa 7) and 0.1 mM (pCa 4) were 
measured because previous studies using sheep RyR2s 
(Laver et al., 1997b) show that Mg2+ inhibition under 
these conditions is determined by different and indepen-
dent mechanisms. At cytoplasmic pCa 7, Mg2+ is a com-
petitive antagonist at the cytoplasmic Ca2+ activation site 
(A site), whereas at pCa 4, Mg2+ inhibits by binding to 
the low-affinity, cytoplasmic Mg2+/Ca2+ inhibition site 
(I1 site; Laver et al., 1997a). At cytoplasmic pCa 7, human 
RyR2s were strongly inhibited by micromolar cytoplas-
mic Mg2+ (Fig. 1 C). RyR2 from human, sheep, and rat 
were all similarly inhibited by cytoplasmic Mg2+ at pCa 7 
(Fig. 1 D). However, at pCa 4, RyR2s from sheep were 
threefold more sensitive to cytoplasmic Mg2+ inhibition 
than those from rat and human.
Human RyR2 could be activated by luminal Ca2+ alone 
(i.e., at subactivating cytoplasmic Ca2+, pCa 7; Fig. 2 A). 
RyR2s from all three species could be activated by lumi-
nal Ca2+ (Fig. 2 B) with a bell-shaped Ca2+ response. How-
ever, there were differences in the luminal Ca2+ responses 
between species. Thus, although RyR2 from human and 
sheep exhibited similar peak activation, rat RyR2 had a 
peak activation that was 10-fold less (P < 0.001). Hill fits 
to the data (Fig. 2 B, solid and dashed curves) give Ka 
values of 35 µM, 12 µM, and 10 µM for human, sheep, 
and rat RyR2s, respectively. The declining phase of the 
luminal Ca2+ response was less pronounced in human 
and could only be detected at luminal pCa 2. The mag-
nitude of the luminal Ca2+ response depended on cyto-
plasmic Ca2+ as shown in Fig. 2 C. At cytoplasmic pCa 7, 
increasing luminal [Ca2+] (from pCa 9 to pCa 4) caused 
increases in open probability in RyR2 from human, 
TA B L E  3
The Hill fit parameters for luminal regulation data shown in Fig. 2
Species [Ca2+]L pCa [Ca2+]C pCa Pmax Pmin (×103) Ka/Ki Ha/Hi n
µM
Activation by luminal Ca2+
Human - 7 0.14 ± 0.03 0.8 ± 0.3 35 ± 12 1.3 ± 0.2 3–17
Sheep - 7 0.19 ± 0.05 0.9 ± 0.4 12 ± 3 2a 3–11
Rat - 7 0.013 ± 0.003b 0.3 ± 0.1 10 ± 7 2a 3–16
Inhibition by luminal Mg2+
Human 4 7 0.09 ± 0.02 0a 550 ± 30 3.8 ± 1.8 5–6
Sheep 4 7 0.10 ± 0.04 0a 650 ± 80 2.0 ± 1.0 4–11
Rat 4 7 0.023 ± 0.011c 0a 78 ± 14b 1.3 ± 0.5 7
n indicates the number of experiments. Hill parameters for luminal Ca2+ inhibition at luminal approximately pCa 3 were poorly determined and 
not shown.
aParameters that were not adjusted during fitting.
bSignificantly different to human (P < 0.01).
cSignificantly different to human (P < 0.05).
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saturating dependencies measured in the absence of 
luminal Mg2+ (Fig. 2). In the presence of luminal Mg2+, 
the RyR2 channels from human and sheep exhibit iden-
tical responses, which were not significantly (P > 0.1) 
different than that shown for RyR2 from rat.
D I S C U S S I ON
Mechanisms for Ca2+ and Mg2+ regulation of RyR2
This study presents a detailed analysis of the regulation 
of human RyR2 by intracellular Ca2+ and Mg2+. We report 
the first measurements of the concentration dependen-
cies of native human RyR2 regulation by luminal and 
cytoplasmic Ca2+ and Mg2+, and we compare these proper-
ties with those of RyR2s from sheep and rat, which have 
been isolated and measured under identical conditions. 
We find that human RyR2 displayed the same Ca2+/Mg2+ 
regulation phenomena as seen in rat and sheep. RyR2 
was activated by cytoplasmic and luminal Ca2+ and in-
hibited by Mg2+ in the lumen and cytoplasm. However, 
although the sensitivity of human and sheep RyR2 to 
luminal Ca2+ and Mg2+ were similar, the rat RyR2 was 
less sensitive to activation by luminal Ca2+ and was more 
sensitive (i.e., a lower Ki) to inhibition by luminal Mg2+.
The molecular mechanism for these differences is not 
yet clear. They could arise from differences in the amino 
acid sequences of the RyR2s, which share 96–98% sim-
ilarity(ExPASy: human Q92736; rat B0LPN4; and sheep 
Q9MZD9). However, the sensitivity to cytoplasmic Ca2+ 
of isolated human native RyR2 reported here (Ka = 4 µM; 
Table 2) is nearly 10-fold lower than that seen in recom-
binant RyR2 in the presence of 50 mM luminal Ca2+ (Ka 
between 0.4 and 0.7 µM [Wehrens et al., 2004]). The dif-
ference could be caused by either (a) factors other than 
amino acid sequence being important in determining 
RyR2 activity or (b) the different concentrations of lumi-
nal Ca2+ used. Species-specific posttranslational modifica-
tions or differing degrees of association with co-proteins 
such as FKBP12/12.6 (Galfré et al., 2012) could be re-
sponsible. For example, the adrenergic tone of rat hearts 
is known to affect the activity of RyR2 isolated from 
these hearts and incorporated into artificial lipid bilay-
ers (Li et al., 2013). It is also possible that variations in 
adrenergic tone (and thus protein phosphorylation) 
between species could underlie the different RyR2 prop-
erties from human, sheep, and rat.
The cytoplasmic Ca2+ activation and Mg2+ inhibition 
of RyR2 observed in several species has been attributed to 
the combined action of a high-affinity Ca2+ activation site 
(Smith et al., 1986; Hymel et al., 1988) and a low-affinity 
divalent cation inhibition site (Meissner, 1986; Laver et al., 
1995, 1997a) located in the cytoplasm-facing domains 
of the RyR2. These sites are referred to here as the A site 
and I1 site after the nomenclature of Balog et al. (2001). 
Mg2+ inhibition that is apparent at submicromolar (dia-
stolic) cytoplasmic Ca2+ occurs because Mg2+ binding oc-
cludes the A site and prevents Ca2+ from binding and 
activating the RyR2, and unlike Ca2+, Mg2+ does not cause 
channel opening. Competition between Ca2+ and Mg2+ 
for the A site reduces the potency of this form of Mg2+ in-
hibition at high (systolic) Ca2+, revealing another Mg2+ 
inhibition mechanism caused by Mg2+ binding to the I1 
site. We found that RyR2s from human, rat, and sheep 
are similarly activated by cytoplasmic Ca2+ and inhibited 
by Mg2+ at cytoplasmic pCa 7 (Fig. 1), suggesting that 
the A sites could be strongly conserved between species. 
However, the different RyR2 sensitivities to cytoplasmic 
Mg2+ seen at cytoplasmic pCa 4 between human and 
sheep indicated interspecies differences in the I1 sites.
Interestingly, there are substantial differences in the 
luminal regulation of RyR2 from rat compared with 
that seen in human and sheep (Fig. 2), where it can be 
seen that rat RyR2 is less activated by luminal Ca2+ and 
more inhibited by luminal Mg2+. Interpreting the pre-
cise mechanism for this phenomenon is complicated by 
the fact that luminal Ca2+ can pass through the channel 
and act via the cytoplasmic facing A site (Tripathy and 
Meissner, 1996; Laver, 2007). However, because the cy-
toplasmic sites produce similar regulation of RyR2 
across species (Fig. 1), the observed differences in RyR2 
inhibition by luminal Mg2+ and activation by luminal 
Ca2+ indicate a divergence in the properties of the L site 
of rat RyR2s from human and sheep.
The importance of luminal Mg2+
The excitability of the SR was shown in early studies to 
be substantially increased by increasing luminal [Ca2+] 
TA B L E  4
The Hill fit parameters for cytoplasmic Ca2+ activation of RyR2 in the presence of 1 mM Mg2+ shown in Fig. 3 A
Species Luminal pCa Pmax Pmin Ka Ha n
µM
Activation by cytoplasmic Ca2+
Human 4 0.55 ± 0.10 0a 25 ± 8 2.6 ± 0.6 4–8
Sheep 4 0.70 ± 0.10 0a 34 ± 5 2.2 ± 0.2 5–10
Rat 4 0.54 ± 0.06 0a 88 ± 9b 3.5 ± 0.4 4–7
n indicates the number of experiments.
aParameters that were not adjusted during fitting.
bSignificantly different to human (P < 0.01).
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(Fabiato and Fabiato, 1977). It is now understood that 
luminal Ca2+ has a direct activating effect on the RyR2 Ca2+ 
release channel (Sitsapesan and Williams, 1997; Györke 
et al., 2002) and that in addition to Ca2+ influx through 
the plasma membrane, Ca2+ in the SR can trigger Ca2+ 
release and so contribute to pacemaking and rhythmic-
ity in cardiac muscle (Vinogradova et al., 2005; Imtiaz 
et al., 2010). The importance of luminal Ca2+ as a deter-
minant of cardiac rhythm is highlighted by arrhythmias 
associated with excessive luminal [Ca2+] (Schlotthauer 
and Bers, 2000). Fig. 3 B shows that RyR2 Po increases 
from 0.007 to almost 0.02, (approximately threefold in-
crease) when luminal [Ca2+] increases from 0.1 to 1 mM. 
This is in agreement with the luminal Ca2+ dependence 
of Ca2+ spark frequency in cardiomyocytes (Zima et al., 
2010). We also show that this dependence on luminal 
Ca2+ over the physiological [Ca2+] range requires the pres-
ence of physiological [Mg2+]. The removal of luminal 
Mg2+ in our bilayer experiments markedly decreased the 
Ka for luminal Ca2+ activation from 1 mM to <0.1 mM, 
causing RyR2 Po to become nearly constant over the 
physio logical range of luminal Ca2+ (Fig. 2 B). These re-
sults suggest that luminal Mg2+ may play an important 
role in the cell in shaping the dose–response of RyR2s to 
store Ca2+ load during diastole.
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